Reporter brief
Multi-ingredient supplement including omega-3s in 12-week RCT showed mixed effects on skin and self-reported outcomes.
What happened
A 12-week double-blind randomised controlled trial tested a multi-ingredient supplement regimen (containing omega-3 fatty acids plus collagen and other components) versus placebo in 35–65 year-olds. Outcomes included skin measurements, hair imaging, cognitive testing, and participant-reported sleep, energy, cognition, and sexual wellbeing. The abstract does not report which outcomes showed differences between groups or the direction or magnitude of effects.
Why it matters
Assessment pending; this report does not establish a change in evidence.
What it does NOT prove
- Limitations have not been recorded; consult the primary source.
Study design and sample
Rct; Human.
Healthy adults aged 35 to 65 years
- Design
- Rct
- Sample
- —
- Journal
- IDI Skincare Limited
- Published
- Sep 18, 2026
Effect size
Not recorded.
Caveats
- Assessment: Superseded.
- Only the source material recorded on this evidence page was assessed.
Conflicts and funding
Sponsored by IDI Skincare Limited; conducted by Eurofins Product Testing Services Ltd (trading as Eurofins Alba) in Edinburgh, United Kingdom · Study sponsored by the manufacturer of the intervention product (IDI Skincare Limited), which is a substantial conflict of interest
Previous evidence
See the Omega-3 fatty acids timeline and recorded assessment for prior evidence.
Primary source
Cancel Death charts and briefs may be reproduced editorially with attribution to CancelDeath.com. This brief is generated from the primary recorded source facts and assessment. Its review status is shown below; verify quotations against the paper before publication.